Evolving trends in the long-term treatment of bipolar disorder

References

• American Psychiatric Association. 2002. Practice guidelines for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 159(Suppl 4):1–50.
   Web of Science ®Google Scholar
• Baldessarini RJ, Tondo L. Does lithium treatment still work? Evidence of stable responses over three decades. Arch Gen Psychiatry 2000; 57: 187–190
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Tondo L, Viguera AC. Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications. Bipolar Disord 1999; 1: 17–24
   PubMedGoogle Scholar
• Baldessarini RJ, Tondo L, Hennen J. Lithium treatment and suicide risk in major affective disorders: update and new findings. J Clin Psychiatry 2003; 64(Suppl 5)44–52
   PubMed Web of Science ®Google Scholar
• Bauer MS, Williford WO, Dawson EE, Akiskal HS, Altshuler L, Fye C, et al. Principles Principles of effectiveness trials and their implementation in VA Cooperative Study #430, ‘Reducing the efficacy-effectiveness gap in bipolar disorder’. J Affect Disord 2001; 67: 61–78
   Google Scholar
• Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 2000a; 57: 481–489
   PubMed Web of Science ®Google Scholar
• Bowden CL, Lecrubier Y, Bauer M, Goodwin G, Greil W, Sachs G, et al. Maintenance therapies for classic and other forms of bipolar disorder. J Affect Disord 2000b; 59(Suppl 1)S57–67
   Google Scholar
• Bowden CL, Calabrese JR, Sachs G, Yatham LN, Asghar SA, Hompland M, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003; 60: 392–400
   PubMed Web of Science ®Google Scholar
• Bowden CL, Grunze H, Mullen J, Brecher M, Paulsson B, Jones M, et al. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J Clin Psychiatry 2005; 66: 111–121
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Vieta E, Shelton MD. Latest maintenance data on lamotrigine in bipolar disorder. Eur Neuropsychopharmacol 2003; 13(Suppl 2)S57–66
   Google Scholar
• Calabrese JR, Keck PE, Jr, Macfadden W. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005; 162: 1351–1360
   PubMed Web of Science ®Google Scholar
• Colom F, Vieta E, Martinez-Aran A, Reinares M, Goikolea JM, Benabarre A, et al. A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry 2003; 60: 402–407
   PubMed Web of Science ®Google Scholar
• Colom F, Vieta E, Sanchez-Moreno J, Martinez-Aran A, Reinares M, Goikolea JM, et al. Stabilizing the stabilizer: Group psychoeducation enhances the stability of serum lithium levels. Bipolar Disord 2005; 7(Suppl 5)32–36
   Google Scholar
• Denicoff KD, Smith-Jackson EE, Disney ER, Ali SO, Leverich GS, Post RM. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry 1997; 58: 470–478
   PubMed Web of Science ®Google Scholar
• Ertugrul A, Meltzer HY. Antipsychotic drugs in bipolar disorder. Int J Neuropsychopharmacol 2003; 6: 277–284
   PubMed Web of Science ®Google Scholar
• Gelenberg AJ, Kane JM, Keller MB, Lavori P, Rosenbaum JF, Cole K, et al. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. New Engl J Med 1989; 321: 1489–1493
   PubMed Web of Science ®Google Scholar
• Ghaemi SN, Goldberg JF, Henry CA, et al. Quetiapine for rapid-cycling bipolar disorder: a long-term follow-up study (abstract). Bipolar Disord 2003; 5(Suppl 1)50
   Google Scholar
• Goodwin G, Vieta E. Effective maintenance treatment – breaking the cycle of bipolar disorder. Eur Psychiatry 2005; 20: 365–371
   PubMedGoogle Scholar
• Gyulai L, Bowden CL, McElroy SL, Calabrese JR, Petty F, Swann AC, et al. Maintenance efficacy of divalproex in the prevention of bipolar depression. Neuropsychopharmacology 2003; 28: 1374–1382
   PubMed Web of Science ®Google Scholar
• Goodwin GM, Geddes JR. Latest maintenance data on lithium in bipolar disorder. Eur Neuropsychopharmacol 2003; 13(Suppl 2)S51–55
   Google Scholar
• Goodwin GM, Bowden CL, Calabrese JR, Grunze H, Kasper S, White R, et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 2004; 65: 432–441
   PubMed Web of Science ®Google Scholar
• Greil W, Ludwig-Mayerhofer W, Erazo N, Schochlin C, Schmidt S, Engel RR, et al. Lithium versus carbamazepine in the maintenance treatment of bipolar disorders – a randomised study. J Affect Disord 1997; 43: 151–161
   PubMed Web of Science ®Google Scholar
• Hartong EGThM, Moleman P, Hoogduin CAL, Broekman TG, Nolen WA, LitCar Group. 2003. Prophylactic efficacy of lithium versus carbamazepine in treatment-naïve bipolar patients. J Clin Psychiatry 64:144–151.
   PubMed Web of Science ®Google Scholar
• Johnson RE, McFarland BH. Lithium use and discontinuation in a health maintenance organization. Am J Psychiatry 1996; 153: 993–1000
   PubMed Web of Science ®Google Scholar
• Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59: 530–537
   PubMed Web of Science ®Google Scholar
• Keck PE, Jr, McElroy SL. Carbamazepine and valproate in the maintenance treatment of bipolar disorder. J Clin Psychiatry 2002; 63(Suppl 10)13–17
   Google Scholar
• Keck PE, Jr, Calabrese JR, McQuade RD, Carson WH, Carlson BX, Rollin LM, et al. Aripiprazole Study Group. A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. J Clin Psychiatry 2006; 67: 626–37
   PubMed Web of Science ®Google Scholar
• Ketter TA, Kalali AH, Weisler RH. A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 2004; 65: 668–673
   PubMed Web of Science ®Google Scholar
• Kleindienst N, Engel R, Greil W. Which clinical factors predict response to prophylactic lithium? A systematic review for bipolar disorders. Bipolar Disord 2005; 7: 404–417
   PubMed Web of Science ®Google Scholar
• Martinez-Aran A, Vieta E, Colom F, Torrent C, Sanchez-Moreno J, Reinares M, et al. Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disord 2004; 6: 224–232
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Brecher M, Paulsson B, Huizar K, Mullen J. Quetiapine or haloperidol as monotherapy for bipolar mania – a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial. Eur Neuropsychopharmacol 2005; 15: 573–585
   PubMed Web of Science ®Google Scholar
• Mendlewicz J, Souery D, Rivelli SK. Short-term and long-term treatment for bipolar patients: beyond the guidelines. J Affect Disord 1999; 55: 79–85
   Google Scholar
• Paulsson B, Jones M. 2004. Sustained remission/euthymia with quetiapine monotherapy for bipolar mania. Presented at the 157th Annual Meeting of the American Psychiatric Association, New York, 1–6 May.
   Google Scholar
• Rybakowski JK, Cholpocka-Wozniak M, Suwalska A. The prophylactic effect of long-term lithium administration in bipolar patients entering treatment in the 1970s and 1980s. Bipolar Disord 2001; 3: 63–67
   PubMed Web of Science ®Google Scholar
• Sachs GS, Thase ME. Bipolar disorder therapeutics: maintenance treatment. Biol Psychiatry 2000; 48: 573–581
   PubMed Web of Science ®Google Scholar
• Sachs GS, Printz D, Kahn DA, Carpenter D, Docherty JP. 2000. The Expert Consensus Guidelines Series. Medication Treatment of Bipolar Disorder 2000. Postgrad Med Special Issue:1–104.
   Google Scholar
• Suppes T, Webb A, Paul B, Carmody T, Kraemer H, Rush AJ. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am J Psychiatry 1999; 156: 1164–1169
   PubMed Web of Science ®Google Scholar
• Tohen M, Jacobs TG, Feldman PD. Onset of action of antipsychotics in the treatment of mania. Bipolar Disord 2 2000; (3 Pt2): 261–268
   Google Scholar
• Tohen M, Ketter TA, Zarate CA, Suppes T, Frye M, Altshuler L, et al. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry 2003a; 160: 1263–1271
   PubMed Web of Science ®Google Scholar
• Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003b; 60: 1079–1088
   PubMed Web of Science ®Google Scholar
• Tohen M, Chengappa KN, Suppes T, Baker RW, Zarate CA, Bowden CL, et al. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone. Br J Psychiatry 2004; 184: 337–345
   PubMed Web of Science ®Google Scholar
• Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, et al. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Am J Psychiatry 2005; 162: 1281–1290
   PubMed Web of Science ®Google Scholar
• Tohen M, Calabrese JR, Sachs GS, Banov MD, Detke HC, Risser R, Baker RW, Chou JC, Bowden CL. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am J Psychiatry 2006; 163: 247–256
   PubMed Web of Science ®Google Scholar
• Vieta E. Divalproex versus olanzapine in mania. J Clin Psychiatry 2003; 64: 1266
   PubMedGoogle Scholar
• Vieta E, Goikolea JM. Atypical antipsychotics: newer options for mania and maintenance therapy. Bipolar Disord 2005; 7(Suppl 4)21–33
   PubMed Web of Science ®Google Scholar
• Vieta E, Goikolea JM, Corbella B, Benabarre A, Reinares M, Martinez G, et al. Group for the Study of Risperidone in Affective Disorders (GSRAD). Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study. J Clin Psychiatry 2001a; 62: 818–825
   PubMed Web of Science ®Google Scholar
• Vieta E, Gasto C, Colom F, Reinares M, Martinez-Aran A, Benabarre A, et al. Role of risperidone in bipolar II. an open 6-month study. J Affect Disord 2001b; 67: 213–219
   PubMed Web of Science ®Google Scholar
• Vieta E, Parramon G, Padrell E, Nieto E, Martinez-Aran A, Corbella B, et al. Quetiapine in the treatment of rapid cycling bipolar disorder. Bipolar Disord 2002; 4: 335–340
   PubMed Web of Science ®Google Scholar
• Vieta E, Mullen J, Brecher M, Paulsson B, Jones M. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies. Curr Med Res Opin 2005; 21: 923–934
   PubMed Web of Science ®Google Scholar